Norway· NO-ID_26FF9182-905C-4579-A62F-75040D0C86CF
Cetrotide
A cetrorelix product containing cetrorelix, registered in Norway by Merck Serono Europe Ltd. The same ATC class is registered in 15 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Cetrorelix is registered in 15 of 19 countries.
Countries holding a registration under ATC H01CC02 (cetrorelix), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 9 of them publish a price we can compare per daily dose
Cetrorelix · ATC H01CC02
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of cetrorelix costs, country by country.
Normalised to the WHO defined daily dose (0.25 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Cetrorelix · price per daily dose (0.25 mg)
USD · FX 28 Sept 2026
- ES Spain$40.95
The record
At a glance
FEST (Norway)- Active substance
- Cetrorelix
- Manufacturer
- Merck Serono Europe Ltd
- Country
- Norway (NO)
- ATC code
- H01CC02
- ATC class
- Cetrorelix
- Defined daily dose
- 0.25 mg, P
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_26FF9182-905C-4579-A62F-75040D0C86CF
- no_varenummer0057661NOK 425.4
- gtin4054839243936
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Cetrorelix in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandCetrorelix Leman 0,25 mg, poudre pour solution injectableLeman SKL SA
- SpainCETRORELIX EDEST 0,25 MG POLVO PARA SOLUCION INYECTABLEIntas Third Party Sales 2005 S.L.
- BelgiumCetrotide 0.25 mgMerck Europe
- United KingdomCetrotide 250microgram powder and solvent for solution for injection vialsMerck Serono Ltd
- IcelandCetrotideMerck Europe B.V.*
- SwedenCetrotide 0,25 mg Pulver och vätska till injektionsvätska, lösningMerck Europe B.V.
- CzechiaCETROTIDEMerck Europe B.V., Amsterdam
- IrelandCetrotide 0.25 mg powder and solvent for solution for injectionMerck Europe B.V.
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Belgium · Ceziboe
- Czechia · Cetrorelix Sun, Ceziboe
- Germany · Ceziboe
- Spain · Ceziboe Sun
- France · Ceziboe
- United Kingdom (Northern Ireland) · Ceziboe
- Greece · Ceziboe
- Hungary · Ceziboe
- Ireland · Ceziboe
- Iceland · Cetrotide
- Italy · Ceziboe
- Liechtenstein · Cetrotide
- Netherlands · Ceziboe
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e13e0ac5-6cd0-447c-a1d3-18c31cbe7f4c GET /v1/drugs/e13e0ac5-6cd0-447c-a1d3-18c31cbe7f4c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Pulver og væske til injeksjonsvæske, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Cetroreliks",
"merkevare_id": "ID_26FF9182-905C-4579-A62F-75040D0C86CF",
"name_form_strength": "Cetrotide pulv+væske til inj oppl 0,25 mg/sprøyte",
"prescription_group": "C"
}See everything about cetrorelix.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.